MOH — authorised 19 December 1978
- Marketing authorisation holder: HQ SPCLT PHARMA
- Status: likely_approved
🇮🇱 Platinol-Aq in Israel
MOH authorised Platinol-Aq on 19 December 1978
Marketing authorisation
Platinol-Aq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Platinol-Aq approved in Israel?
Yes. MOH authorised it on 19 December 1978.
Who is the marketing authorisation holder for Platinol-Aq in Israel?
HQ SPCLT PHARMA holds the Israeli marketing authorisation.